MedTrace Logo

Combination of Supplements for Treating Autistic Spectrum Disorder

NCT06756711 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2025-01-03

No results posted yet for this study

Summary

A pilot study to compare the efficacy of a combination of apitherapy supplements versus placebo in children with autistic spectrum disorder.

Conditions

  • Autism Spectrum Disorder (ASD

Interventions

DIETARY_SUPPLEMENT

A combination of apitherapy and plant extracts

This combination contains the active comparator

COMBINATION_PRODUCT

Placebo Combination

A combination containing inert substances - placebo

Sponsors & Collaborators

  • Fundatia Bio-Forum

    lead OTHER

Principal Investigators

  • Felician Stancioiu, M.D. · Fundatia Bio-Forum

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
3 Years
Max Age
14 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-12-10
Primary Completion
2025-09-30
Completion
2025-09-30

Countries

  • Romania

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06756711 on ClinicalTrials.gov